Cosentyx is a biologic medication that is used to treat various inflammatory conditions. It is a human monoclonal antibody that binds to a protein called interleukin-17A (IL-17A), which is involved in the immune response that causes inflammation. Cosentyx can help to reduce inflammation and improve symptoms in people with certain conditions.

One condition that Cosentyx can treat is psoriasis. Psoriasis is a chronic autoimmune condition that causes red, scaly patches on the skin. Cosentyx works by blocking IL-17A, which is involved in the inflammation that causes psoriasis [1].

Cosentyx can also be used to treat psoriatic arthritis, which is a type of arthritis that can occur in people with psoriasis. Cosentyx can help to reduce joint pain and swelling, and improve physical function in people with psoriatic arthritis [2].

Another condition that Cosentyx can treat is ankylosing spondylitis. Ankylosing spondylitis is a type of arthritis that primarily affects the spine. Cosentyx can help to reduce inflammation in the spine and improve mobility in people with ankylosing spondylitis [2].

In addition, Cosentyx has been approved to treat non-radiographic axial spondyloarthritis, which is a type of inflammatory arthritis that primarily affects the spine and sacroiliac joints. Cosentyx can help to reduce inflammation and improve symptoms in people with this condition [3].

Overall, Cosentyx is a biologic medication that can be used to treat several inflammatory conditions, including psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. It works by blocking IL-17A, which is involved in the inflammation that causes these conditions.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] https://www.cosentyx.com/ankylosing-spondylitis/how-cosentyx-works
[3] https://www.medicalnewstoday.com/articles/326632